Literature DB >> 10202582

D-fenfluramine challenge in posttraumatic stress disorder.

L L Davis1, D M Clark, G L Kramer, F G Moeller, F Petty.   

Abstract

BACKGROUND: Much progress has been made in understanding the role of catecholamines in the pathophysiology of posttraumatic stress disorder (PTSD). Recent research has broadened the scope of neuroregulation of PTSD to include serotonin.
METHODS: We used the serotonin-releasing agent and reuptake inhibitor, d-fenfluramine, to assess the integrity of the serotonin-mediated prolactin release in 8 men with combat-induced PTSD and 8 healthy men.
RESULTS: The veterans with PTSD had a significantly lower prolactin response to d-fenfluramine as compared to healthy control subjects. The prolactin response to d-fenfluramine was inversely correlated with the patient's level of PTSD symptomatology and measures of aggression.
CONCLUSIONS: This study demonstrates a central serotonin dysfunction, as reflected in a lower prolactin response to d-fenfluramine, in patients with PTSD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202582     DOI: 10.1016/s0006-3223(98)00215-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  6 in total

Review 1.  Posttraumatic stress disorder in children and adolescents: a review of psychopharmacological treatment.

Authors:  J Huemer; F Erhart; H Steiner
Journal:  Child Psychiatry Hum Dev       Date:  2010-12

Review 2.  Genetics of anxiety and trauma-related disorders.

Authors:  S D Norrholm; K J Ressler
Journal:  Neuroscience       Date:  2009-06-18       Impact factor: 3.590

Review 3.  Revisiting the serotonin-aggression relation in humans: a meta-analysis.

Authors:  Aaron A Duke; Laurent Bègue; Rob Bell; Tory Eisenlohr-Moul
Journal:  Psychol Bull       Date:  2013-02-04       Impact factor: 17.737

4.  The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding.

Authors:  James W Murrough; Christoph Czermak; Shannan Henry; Nabeel Nabulsi; Jean-Dominique Gallezot; Ralitza Gueorguieva; Beata Planeta-Wilson; John H Krystal; John F Neumaier; Yiyun Huang; Yu-Shin Ding; Richard E Carson; Alexander Neumeister
Journal:  Arch Gen Psychiatry       Date:  2011-09

5.  Circulating levels of hormones, lipids, and immune mediators in post-traumatic stress disorder - a 3-month follow-up study.

Authors:  Mladen Jergović; Krešo Bendelja; Ana Savić Mlakar; Valerija Vojvoda; Neda Aberle; Tanja Jovanovic; Sabina Rabatić; Ante Sabioncello; Anđelko Vidović
Journal:  Front Psychiatry       Date:  2015-04-14       Impact factor: 4.157

6.  The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication.

Authors:  M Fava; I Hwang; A J Rush; N Sampson; E E Walters; R C Kessler
Journal:  Mol Psychiatry       Date:  2009-03-10       Impact factor: 15.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.